Study of DITPA in Patients With Congestive Heart Failure

PHASE2TerminatedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Heart Failure, Congestive
Interventions
DRUG

DITPA (3,5-diiodothyropropionic acid)

DRUG

Placebo

Placebo

Trial Locations (22)

10032

Columbia University New York Presbyterian Hospital, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

17033

Milton S. Hershey Medical Center, Hershey

22908

The University of Virginia Health System, Charlottesville

30342

Saint Joseph's Research Institute, Atlanta

35806

The Heart Center, Huntsville

40202

University of Louisville, Louisville

44195

Clevaland Clinic Foundation, Cleveland

45220

Cincinnati VA Medical Center, Cincinnati

53705

William S. Middleton Memorial Veterans Hospital, Madison

55905

Mayo Clinic, Rochester

60612

Rush University Medical Center, Chicago

71103

Louisiana State University Health Science Center, Shreveport

73120

Oklahoma Foundation for Cardiovascular Research, Oklahoma City

75226

Baylor University Medical Center Heart Place, Dallas

85381

Cardiac Solutions, Peoria

85724

University of Arizona Sarver Heart Center, Tucson

90033

University of Southern California, Los Angeles

90095

UCLA Medical Center, Los Angeles

94143

University of California, San Francisco, San Francisco

94598

Cardiovascular Consultants Medical Group, Walnut Creek

97239

Oregon Health Sciences University, Portland

Sponsors
All Listed Sponsors
lead

Titan Pharmaceuticals

INDUSTRY

NCT00103519 - Study of DITPA in Patients With Congestive Heart Failure | Biotech Hunter | Biotech Hunter